How we helped assess the asthma market landscape in emerging markets.
Common forms of lung disease such as asthma, emphysema, chronic obstructive pulmonary disorder and chronic bronchitis affect large populations globally and are caused by a combination of genetic, environmental and lifestyle factors. The main risk factor for COPD, which is believed to affect 5% of the population globally, is smoking. Although there are effective therapies to treat this and associated diseases such as emphysema and chronic bronchitis, patients are often non-compliant with both taking their medication and following lifestyle advice. Research Partnership has conducted significant research with patients and physicians to understand compliance, and has had success using mobile methodologies to gather in-the-moment insights into patient behaviour. We can also help you with:
Opportunity and demand assessment
Understanding the global and local market opportunity
Segmenting the market
Product and portfolio development
Brand positioning, launch and beyond
We offer a syndicated report based on quantitative research with patients in 2EU, US & Japan, which provides valuable insights into patients' emotions, attitudes, behaviours, treatments and unmet needs.
This research can be used to understand: